claim
Posted by admin
•
August 21, 2026 at 04:02 PM
GLP-1 drugs should be reserved for people with type 2 diabetes or severe obesity, not marketed as cosmetic weight-loss tools for the general public.
Vote to see results
Responses & Discussion
Log in to add your response to this statement
Log InNo responses yet. Be the first to share your perspective!